blog

Industry insights from our own scientists, publicists, developers, designers, strategists and more.

Our experts have spent their careers learning their craft, honing their skills and implementing the most effective marketing, engagement and public relations strategies to help healthcare and science brands transform the world. Let's dive in, shall we?

Other insights

Nintendo’s PR Game Needs a Patch. Here’s What Biotech Can Learn.

Nintendo’s Switch 2 reveal sparked backlash due to unclear communication—offering valuable lessons for biotech companies to think about.

Azeem Zeekrya | April 24, 2025

Marketing | Corporate Communications | Best Practices | Current Affairs | Public Relations

Is the Recent CRISPR “Doom-and-Gloom” Narrative Missing the Bigger Picture?

Once biotech's golden child, CRISPR now faces doubts from investors. Is this a downturn or a turning point for the CRISPR industry?

John Kang | March 20, 2025

Life Sciences | Current Affairs

NIH Budget Cuts: A Threat to Scientific Progress

Proposed cuts to the National Institutes of Health (NIH) budget—including a sharp reduction in indirect cost reimbursements—threaten to destabilize the very foundation of biomedical research in the United States.

Dillon Allie | February 13, 2025

Biotech | Life Sciences | Current Affairs

Trump, China’s Rise and The Forces Shaping Biotech’s Future

This year, the industry was rocked by the aftermath of UnitedHealthcare CEO Brian Thompson’s tragic murder last December, which led 11 major health insurance companies to quietly withdraw from JPM last week. Heightened security, bomb-sniffing dogs, and a palpable sense of caution surrounded Union Square. Thankfully, the conference, itself, concluded without incident.

John Kang | January 21, 2025

Conferences & Events | Biotech | Current Affairs

Chicago’s emerging role as a biotech hub

Chicago has started gaining recognition for its biotech scene. See why we’re excited about its potential as a leader in the industry.

Dillon Allie | December 20, 2024

Business | Current Affairs | Life Sciences

Halfway through 2024, cautious optimists have reason to celebrate

BIO 2024 serves a mid-year barometer for how the life sciences industry is faring, and so far, the industry has responded with excitement.

Azeem Zeekrya, Director, Public Relations | June 17, 2024

Small Molecules are Exciting Again with AI’s Help

Our experts have been closely watching the AI gold rush in biotech and think that it will lead to a boom in small molecule drug development.

Azeem Zeekrya, Director, Public Relations | March 27, 2024

With Major Government Support, Biotech and Life Sciences Likely Heading Into Innovation Renaissance

Read this week’s blog post to see how Biden’s new executive order may spark biotech, healthcare and life sciences innovations and startups.

Azeem Zeekrya, Associate Director, Scientific Communications | October 24, 2022

Biotech | Life Sciences | Current Affairs